Magnetic nanovectors for the development of DNA blood-stage malaria vaccines

Fatin M. Nawwab Al-Deen, Sue D. Xiang, Charles Ma, Kirsty Wilson, Ross Coppel, Cordelia Selomulya, Magdalena Plebanski

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


DNA vaccines offer cost, flexibility, and stability advantages, but administered alone have limited immunogenicity. Previously, we identified optimal configurations of magnetic vectors comprising superparamagnetic iron oxide nanoparticles (SPIONs), polyethylenimine (PEI), and hyaluronic acid (HA) to deliver malaria DNA encoding Plasmodium yoelii (Py) merozoite surface protein MSP119 (SPIONs/PEI/DNA + HA gene complex) to dendritic cells and transfect them with high efficiency in vitro. Herein, we evaluate their immunogenicity in vivo by administering these potential vaccine complexes into BALB/c mice. The complexes induced antibodies against PyMSP119, with higher responses induced intraperitoneally than intramuscularly, and antibody levels further enhanced by applying an external magnetic field. The predominant IgG subclasses induced were IgG2a followed by IgG1 and IgG2b. The complexes further elicited high levels of interferon gamma (IFN-γ), and moderate levels of interleukin (IL)-4 and IL-17 antigen-specific splenocytes, indicating induction of T helper 1 (Th1), Th2, and Th17 cell mediated immunity. The ability of such DNA/nanoparticle complexes to induce cytophilic antibodies together with broad spectrum cellular immunity may benefit malaria vaccines.

Original languageEnglish
Article number30
Number of pages17
Issue number2
Publication statusPublished - 10 Feb 2017


  • Hyaluronic acid
  • MSP119
  • Superparamagnetic iron oxide nanoparticles (SPIONs)
  • Magnetic gene vector
  • Malaria DNA vaccine
  • Antibody
  • Immune response

Cite this